Bunge Investments increased by 4.4% to $142.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.9%, from $175.00M to $142.00M. Over 2 years (FY 2023 to FY 2025), Investments shows relatively stable performance with a -2.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in this area suggests the company is deploying excess capital into long-term wealth-generating assets.
These are investments in securities, joint ventures, or other long-term financial assets that the company intends to hol...
Common in large, diversified healthcare firms that manage significant investment portfolios.
non_current_assets_long_term_investments| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $142.00M | $159.00M | $168.00M | $174.00M | $174.00M | $175.00M | $172.00M | $181.00M | $136.00M | $142.00M |
| QoQ Change | — | +12.0% | +5.7% | +3.6% | +0.0% | +0.6% | -1.7% | +5.2% | -24.9% | +4.4% |
| YoY Change | — | — | — | — | +22.5% | +10.1% | +2.4% | +4.0% | -21.8% | -18.9% |